BICLUSTER_ID : UPREG-84
PATHOGENS /3/ : streptococcus pneumoniae,helicobacter pylori,ehrlichia chaffeensis
TARGETS /6/ : SELP, IL6, CCL20, JUN, PIM1, PLAUR
Gene SetLeading Edge Genes
NETPATH IL 1 PATHWAY UPRHOB, BIRC3, CCL20, JUN, CXCL1, NFKBIE, HBEGF, NFKBIA, IL6, PBEF1, CXCL2, MYC
NETPATH IL 2 PATHWAY UPSTK17B, KLF6, JUN, GADD45G, RBL1, ETS2, PMAIP1, IL6, PBEF1, MYC, PLAUR, IER3
NCI IL6 7PATHWAYLMO4, IL6, CEBPD, JUN, JUNB, MYC
NETPATH IL 4 PATHWAY UPSTK17B, IL6, MXD1, JUN, IBRDC3, BCL2L11, MYC
GERY CEBP TARGETSGADD45B, CXCL1, EREG, JUNB, HBEGF, GADD45G, ATF3, PIM1, MAFK, PLAUR, BTG2
NCI ATF2 PATHWAYIL6, ATF3, JUN
NETPATH IL 4 PATHWAY DOWNNFKBIA, IL6, GEM, CCL20, GADD45B, CXCL2, DDIT4
NETPATH KIT RECEPTOR PATHWAY UPGDF15, IL6, JUNB, PIM1, MYC, IER3
NETPATH IL 6 PATHWAY UPMAFF, GADD45B, CXCL1, CEBPD, JUN, JUNB, PIM1, MAP3K8
NETPATH IL 5 PATHWAY UPBIRC3, SELP, NFKB2, NFKBIE, PIM1, HBEGF, IER3
NETPATH IL 7 PATHWAY UPCXCL1, JUN, CXCL2, MYC
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
TURJANSKI MAPK7 TARGETS
NETPATH IL 9 PATHWAY UPJUNB, MYC
MAHAJAN RESPONSE TO IL1A UP
BIOCARTA IL6 PATHWAY
MARTORIATI MDM4 TARGETS NEUROEPITHELIUM UP
CHUANG OXIDATIVE STRESS RESPONSE UP
VARELA ZMPSTE24 TARGETS UP
CHEN LVAD SUPPORT OF FAILING HEART UP
TENEDINI MEGAKARYOCYTE MARKERS
LINDSTEDT DENDRITIC CELL MATURATION B
RASHI RESPONSE TO IONIZING RADIATION 2
LINDSTEDT DENDRITIC CELL MATURATION A
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
ELVIDGE HYPOXIA UP
IYENGAR RESPONSE TO ADIPOCYTE FACTORS
AMIT EGF RESPONSE 40 HELA
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
MORI EMU MYC LYMPHOMA BY ONSET TIME DN
JEON SMAD6 TARGETS UP
MITSIADES RESPONSE TO APLIDIN UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
HASINA NOL7 TARGETS UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
LENAOUR DENDRITIC CELL MATURATION DN
MARTORIATI MDM4 TARGETS FETAL LIVER UP
HINATA NFKB TARGETS KERATINOCYTE UP
GENTILE UV HIGH DOSE UP
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
DAZARD UV RESPONSE CLUSTER G3
NCI HIF1 TFPATHWAY
OSADA ASCL1 TARGETS DN
DUTTA APOPTOSIS VIA NFKB
COULOUARN TEMPORAL TGFB1 SIGNATURE UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS MAGENTA UP
PAL PRMT5 TARGETS DN
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER DN
NCI MYC REPRESSPATHWAY
TSAI RESPONSE TO IONIZING RADIATION
DIRMEIER LMP1 RESPONSE EARLY
DER IFN GAMMA RESPONSE UP
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY DN
SEMENZA HIF1 TARGETS
NCI REG GR PATHWAY
BIOCARTA CD40 PATHWAY
BIOCARTA ETS PATHWAY
NCI NFAT TFPATHWAY
ZHOU INFLAMMATORY RESPONSE LIVE UP
ONDER CDH1 TARGETS 3 DN
DEBOSSCHER NFKB TARGETS REPRESSED BY GLUCOCORTICOIDS
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS RED UP
AMIT EGF RESPONSE 120 HELA
DANG REGULATED BY MYC DN
BIOCARTA RANKL PATHWAY
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
DAZARD RESPONSE TO UV NHEK UP
MCLACHLAN DENTAL CARIES UP
WINTER HYPOXIA METAGENE
GAJATE RESPONSE TO TRABECTEDIN UP
HENDRICKS SMARCA4 TARGETS DN
PODAR RESPONSE TO ADAPHOSTIN UP
BEGUM TARGETS OF PAX3 FOXO1 FUSION DN
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS TURQUOISE UP
FOSTER INFLAMMATORY RESPONSE LPS DN
LEE LIVER CANCER E2F1 UP
TAVOR CEBPA TARGETS UP
GAURNIER PSMD4 TARGETS
KERLEY RESPONSE TO CISPLATIN UP
LAU APOPTOSIS CDKN2A UP
ZHOU INFLAMMATORY RESPONSE LPS UP
GESERICK TERT TARGETS DN
NETPATH TGFBETA RECEPTOR PATHWAY DOWN
CLASPER LYMPHATIC VESSELS DURING METASTASIS UP
AMIT SERUM RESPONSE 120 MCF10A
BROWNE HCMV INFECTION 2HR UP
BERENJENO TRANSFORMED BY RHOA UP
DORN ADENOVIRUS INFECTION 24HR DN
CORUM REL-MAP3K8-RELA-TNIP2-PAPOLA COMPLEX
SESTO RESPONSE TO UV C3
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
AMIT EGF RESPONSE 40 MCF10A
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
NCI P53DOWNSTREAMPATHWAY
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX RPL6 RPL30 RPS13 CHUK DDX3X NFKB2 NFKBIB REL IKBKG NFKB1 MAP3K8 RELB GLG1 NFKBIA RELA TNIP2 GTF2I
GENTILE UV HIGH DOSE DN
BOYLAN MULTIPLE MYELOMA C CLUSTER DN
ST TUMOR NECROSIS FACTOR PATHWAY
BIOCARTA ATM PATHWAY
ZHOU INFLAMMATORY RESPONSE FIMA UP
CHASSOT SKIN WOUND
TIAN TNF SIGNALING VIA NFKB
ABE VEGFA TARGETS 2HR
GENTILE UV LOW DOSE UP
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
AMIT DELAYED EARLY GENES
KRIGE AMINO ACID DEPRIVATION
AMIT EGF RESPONSE 60 MCF10A
HINATA NFKB TARGETS FIBROBLAST UP
NOJIMA SFRP2 TARGETS UP
MISSIAGLIA REGULATED BY METHYLATION UP
CHEN HOXA5 TARGETS 6HR UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
NCI TCRCALCIUMPATHWAY
LEONARD HYPOXIA
GEORGANTAS HSC MARKERS
DORN ADENOVIRUS INFECTION 32HR DN
CROONQUIST STROMAL STIMULATION UP
LEE LIVER CANCER MYC TGFA UP
BERENJENO TRANSFORMED BY RHOA REVERSIBLY DN
ONDER CDH1 TARGETS 1 UP
HALMOS CEBPA TARGETS UP
DORN ADENOVIRUS INFECTION 48HR UP
ZHANG RESPONSE TO CANTHARIDIN UP
SAGIV CD24 TARGETS DN
KRIGE RESPONSE TO TOSEDOSTAT 24HR UP
KEGG MAPK SIGNALING PATHWAY
BIOCARTA CDMAC PATHWAY
NCI CMYB PATHWAY
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
AMIT EGF RESPONSE 480 MCF10A
GAUTSCHI SRC SIGNALING
MAHADEVAN RESPONSE TO MP470 DN
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
EHRLICH ICF SYNDROM DN
DORN ADENOVIRUS INFECTION 12HR DN
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
HARRIS HYPOXIA
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLACK UP
SCHAVOLT TARGETS OF TP53 AND TP63
KOKKINAKIS METHIONINE DEPRIVATION 48HR UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA UP
NUNODA RESPONSE TO DASATINIB IMATINIB UP
AMIT EGF RESPONSE 20 HELA
KAN RESPONSE TO ARSENIC TRIOXIDE
BASSO CD40 SIGNALING UP
MUELLER METHYLATED IN GLIOBLASTOMA
BIOCARTA NTHI PATHWAY
MARZEC IL2 SIGNALING UP
NAGASHIMA NRG1 SIGNALING UP
SOUCEK MYC TARGETS
CORUM IKBALPHA-RELA-CREL COMPLEX
ENK UV RESPONSE EPIDERMIS DN
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
ZERBINI RESPONSE TO SULINDAC UP
SCIAN INVERSED TARGETS OF TP53 AND TP73 DN
FRIDMAN SENESCENCE UP
WU HBX TARGETS 2 DN
GENTILE UV LOW DOSE DN
NETPATH B CELL RECEPTOR PATHWAY UP
MAHADEVAN RESPONSE TO MP470 UP
FERRARI RESPONSE TO FENRETINIDE UP
BILD HRAS ONCOGENIC SIGNATURE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
NETPATH IL 3 PATHWAY UPMYC
ELVIDGE HIF1A AND HIF2A TARGETS DN
WANG ESOPHAGUS CANCER PROGRESSION UP
WU HBX TARGETS 1 UP
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
AMIT EGF RESPONSE 60 HELA
BERENJENO TRANSFORMED BY RHOA FOREVER DN
KANNAN TP53 TARGETS UP
AMUNDSON DNA DAMAGE RESPONSE TP53
CHEN HOXA5 TARGETS 9HR UP
DAZARD UV RESPONSE CLUSTER G2
NCI CD40 PATHWAY
AMIT SERUM RESPONSE 40 MCF10A
SEKI INFLAMMATORY RESPONSE LPS UP
NETPATH EGFR1 PATHWAY UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
PARK TRETINOIN RESPONSE AND PML RARA FUSION
HELLER SILENCED BY METHYLATION DN
ENGELMANN CANCER PROGENITORS UP
BIERIE INFLAMMATORY RESPONSE TGFB1
BUYTAERT PHOTODYNAMIC THERAPY STRESS UP
MARSON FOXP3 TARGETS DN
SENESE HDAC1 AND HDAC2 TARGETS UP
WANG METHYLATED IN BREAST CANCER
XU HGF TARGETS INDUCED BY AKT1 6HR
MATTIOLI MGUS VS PCL
ONDER CDH1 TARGETS 2 DN
SENESE HDAC1 TARGETS UP
MANALO HYPOXIA UP
INGA TP53 TARGETS
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
ODONNELL TARGETS OF MYC AND TFRC UP
UDAYAKUMAR MED1 TARGETS DN
KIM WT1 TARGETS UP
SENESE HDAC3 TARGETS UP
ONDER CDH1 TARGETS 1 DN
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
XU HGF SIGNALING NOT VIA AKT1 6HR
BIOCARTA KERATINOCYTE PATHWAY
BIOCARTA TNFR2 PATHWAY
HESS TARGETS OF HOXA9 AND MEIS1 DN
ELVIDGE HYPOXIA BY DMOG UP
DASU IL6 SIGNALING UP
AMIT EGF RESPONSE 120 MCF10A
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
GOUYER TATI TARGETS UP
MURAKAMI UV RESPONSE 6HR DN
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
ZUCCHI METASTASIS DN
BERENJENO ROCK SIGNALING NOT VIA RHOA DN
BIOCARTA ARENRF2 PATHWAY
PRAMOONJAGO SOX4 TARGETS UP
KIM WT1 TARGETS 8HR UP
CORUM ETS2-FOS-JUN COMPLEX
NCI TCRJNKPATHWAY
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
ELVIDGE HIF1A TARGETS DN
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
helicobacter pylori kx1 mgepehrlichia chaffeensis wakullastreptococcus pneumoniae tigr4GeneSet Name
0.00000 0.00022 0.00001NETPATH_IL_1_PATHWAY_UP
0.02575 0.00006 0.07061NETPATH_IL_2_PATHWAY_UP
0.04616 0.00000 0.00381NCI_IL6_7PATHWAY
0.00423 0.00000 0.00685NETPATH_IL_4_PATHWAY_UP
0.00133 0.00116 0.00001GERY_CEBP_TARGETS
0.02072 0.00196 0.00028NCI_ATF2_PATHWAY
0.00002 0.00000 0.01938NETPATH_IL_4_PATHWAY_DOWN
0.00065 0.00015 0.00001NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.00236 0.00000 0.00000NETPATH_IL_6_PATHWAY_UP
0.00021 0.00000 0.00002NETPATH_IL_5_PATHWAY_UP
0.00294 0.00004 0.00009NETPATH_IL_7_PATHWAY_UP
0.03509 0.00547 0.00058GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.05499 0.06383 0.00842TURJANSKI_MAPK7_TARGETS
0.00013 0.00000 0.05141NETPATH_IL_9_PATHWAY_UP
0.00517 0.00447 0.00006MAHAJAN_RESPONSE_TO_IL1A_UP
0.02454 0.12285 0.01655BIOCARTA_IL6_PATHWAY
0.01240 0.05648 0.05839MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
0.01119 0.12450 0.00051CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.00006 0.00013 0.00000VARELA_ZMPSTE24_TARGETS_UP
0.00038 0.01382 0.00000CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.11465 0.00000 0.00292TENEDINI_MEGAKARYOCYTE_MARKERS
0.00000 0.00000 0.00796LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00000 0.00001 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00015 0.00000 0.15403LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.00132 0.02903 0.02026LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.00083 0.00027 0.00000ELVIDGE_HYPOXIA_UP
0.00293 0.01247 0.08439IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.00125 0.00042 0.00000AMIT_EGF_RESPONSE_40_HELA
0.00012 0.02739 0.00224YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.17135 0.01382 0.04977MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.00006 0.00032 0.11902JEON_SMAD6_TARGETS_UP
0.00011 0.03497 0.00323MITSIADES_RESPONSE_TO_APLIDIN_UP
0.00000 0.00174 0.00077THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.03175 0.14172 0.00656HASINA_NOL7_TARGETS_UP
0.10179 0.00001 0.07760TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.11960 0.00000 0.02611LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.03610 0.13788 0.00087MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
0.00002 0.00001 0.00741HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.00330 0.19789 0.00764GENTILE_UV_HIGH_DOSE_UP
0.10157 0.11672 0.00726KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.00005 0.00000 0.02561KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.06558 0.03040 0.03617DAZARD_UV_RESPONSE_CLUSTER_G3
0.00065 0.01765 0.00001NCI_HIF1_TFPATHWAY
0.10172 0.00002 0.09859OSADA_ASCL1_TARGETS_DN
0.00000 0.00000 0.00090DUTTA_APOPTOSIS_VIA_NFKB
0.02584 0.00777 0.02113COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.04809 0.04386 0.00000GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.00084 0.00109 0.02551PAL_PRMT5_TARGETS_DN
0.16134 0.06793 0.13655SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN
0.06699 0.10943 0.06003NCI_MYC_REPRESSPATHWAY
0.00508 0.00000 0.03596TSAI_RESPONSE_TO_IONIZING_RADIATION
0.00157 0.00000 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.03795 0.00650 0.17933DER_IFN_GAMMA_RESPONSE_UP
0.04004 0.00259 0.11158RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.00102 0.02278 0.00001SEMENZA_HIF1_TARGETS
0.16033 0.14236 0.01495NCI_REG_GR_PATHWAY
0.02889 0.04824 0.06184BIOCARTA_CD40_PATHWAY
0.09100 0.02668 0.04543BIOCARTA_ETS_PATHWAY
0.11283 0.01648 0.00004NCI_NFAT_TFPATHWAY
0.00000 0.00039 0.00172ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.00085 0.00507 0.00000ONDER_CDH1_TARGETS_3_DN
0.09299 0.16910 0.18502DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.00062 0.00872 0.19787GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
0.00003 0.00037 0.00000AMIT_EGF_RESPONSE_120_HELA
0.13597 0.00067 0.00565DANG_REGULATED_BY_MYC_DN
0.02627 0.01515 0.05739BIOCARTA_RANKL_PATHWAY
0.01988 0.00276 0.05863NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.00624 0.05265 0.00000DAZARD_RESPONSE_TO_UV_NHEK_UP
0.00018 0.00000 0.18322MCLACHLAN_DENTAL_CARIES_UP
0.00017 0.01067 0.00002WINTER_HYPOXIA_METAGENE
0.09307 0.00261 0.00103GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.06006 0.02717 0.00439HENDRICKS_SMARCA4_TARGETS_DN
0.00015 0.00028 0.00000PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.11968 0.00717 0.19127BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.00151 0.13273 0.00001GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.00006 0.00000 0.01424FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.17072 0.00000 0.09181LEE_LIVER_CANCER_E2F1_UP
0.03788 0.00085 0.01378TAVOR_CEBPA_TARGETS_UP
0.00002 0.00000 0.09452GAURNIER_PSMD4_TARGETS
0.02159 0.00855 0.00312KERLEY_RESPONSE_TO_CISPLATIN_UP
0.00207 0.00442 0.00272LAU_APOPTOSIS_CDKN2A_UP
0.00307 0.00012 0.05005ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.00257 0.00032 0.00000GESERICK_TERT_TARGETS_DN
0.14159 0.00363 0.05146NETPATH_TGFBETA_RECEPTOR_PATHWAY_DOWN
0.01277 0.00039 0.13640CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP
0.00289 0.00009 0.00000AMIT_SERUM_RESPONSE_120_MCF10A
0.00034 0.11885 0.00000BROWNE_HCMV_INFECTION_2HR_UP
0.03867 0.00506 0.02776BERENJENO_TRANSFORMED_BY_RHOA_UP
0.00013 0.07444 0.00000DORN_ADENOVIRUS_INFECTION_24HR_DN
0.12111 0.16009 0.11125CORUM_REL-MAP3K8-RELA-TNIP2-PAPOLA_COMPLEX
0.00438 0.01412 0.00000SESTO_RESPONSE_TO_UV_C3
0.00063 0.00000 0.01022VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.01130 0.00000 0.00015BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.05254 0.01188 0.00000AMIT_EGF_RESPONSE_40_MCF10A
0.00000 0.00022 0.03793GEISS_RESPONSE_TO_DSRNA_UP
0.11276 0.00030 0.00170GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.03315 0.03452 0.00000NCI_P53DOWNSTREAMPATHWAY
0.03787 0.06742 0.09063CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_RPL6_RPL30_RPS13_CHUK_DDX3X_NFKB2_NFKBIB_REL_IKBKG_NFKB1_MAP3K8_RELB_GLG1_NFKBIA_RELA_TNIP2__GTF2I
0.00807 0.12305 0.00050GENTILE_UV_HIGH_DOSE_DN
0.07759 0.04558 0.01366BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN
0.00032 0.00254 0.10060ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.01028 0.02026 0.01950BIOCARTA_ATM_PATHWAY
0.00157 0.02576 0.02569ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.01494 0.04468 0.00000CHASSOT_SKIN_WOUND
0.00000 0.00000 0.00001TIAN_TNF_SIGNALING_VIA_NFKB
0.15162 0.10928 0.01936ABE_VEGFA_TARGETS_2HR
0.07690 0.07239 0.00028GENTILE_UV_LOW_DOSE_UP
0.07700 0.00011 0.01752LEE_LIVER_CANCER_HEPATOBLAST
0.00000 0.00000 0.00000NAGASHIMA_EGF_SIGNALING_UP
0.00013 0.00462 0.00000AMIT_DELAYED_EARLY_GENES
0.00000 0.04509 0.00068KRIGE_AMINO_ACID_DEPRIVATION
0.00002 0.00070 0.00000AMIT_EGF_RESPONSE_60_MCF10A
0.00000 0.00151 0.00038HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.00032 0.00340 0.00000NOJIMA_SFRP2_TARGETS_UP
0.00725 0.00006 0.05746MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.00126 0.01388 0.00007CHEN_HOXA5_TARGETS_6HR_UP
0.07692 0.00000 0.00812SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00008 0.00301 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.17276 0.05207 0.00024NCI_TCRCALCIUMPATHWAY
0.00002 0.00008 0.00001LEONARD_HYPOXIA
0.16428 0.00835 0.10534GEORGANTAS_HSC_MARKERS
0.00013 0.17242 0.00000DORN_ADENOVIRUS_INFECTION_32HR_DN
0.03674 0.00000 0.00000CROONQUIST_STROMAL_STIMULATION_UP
0.11284 0.00000 0.14214LEE_LIVER_CANCER_MYC_TGFA_UP
0.07481 0.00483 0.00179BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
0.11224 0.14764 0.06833ONDER_CDH1_TARGETS_1_UP
0.01235 0.00175 0.00000HALMOS_CEBPA_TARGETS_UP
0.12187 0.04795 0.15543DORN_ADENOVIRUS_INFECTION_48HR_UP
0.00152 0.03702 0.05948ZHANG_RESPONSE_TO_CANTHARIDIN_UP
0.03235 0.00451 0.00002SAGIV_CD24_TARGETS_DN
0.12831 0.00165 0.16308KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
0.18732 0.00443 0.03665KEGG_MAPK_SIGNALING_PATHWAY
0.07831 0.12269 0.00114BIOCARTA_CDMAC_PATHWAY
0.09292 0.02081 0.12428NCI_CMYB_PATHWAY
0.08369 0.02715 0.00068GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.00909 0.19773 0.14948AMIT_EGF_RESPONSE_480_MCF10A
0.08537 0.03295 0.03607GAUTSCHI_SRC_SIGNALING
0.00340 0.08720 0.00000MAHADEVAN_RESPONSE_TO_MP470_DN
0.13491 0.00000 0.07880RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.05594 0.01539 0.03720EHRLICH_ICF_SYNDROM_DN
0.00586 0.19163 0.00432DORN_ADENOVIRUS_INFECTION_12HR_DN
0.09986 0.00022 0.07890CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.00027 0.00025 0.00000HARRIS_HYPOXIA
0.05246 0.02072 0.02297GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.10952 0.14927 0.00046SCHAVOLT_TARGETS_OF_TP53_AND_TP63
0.04563 0.02669 0.00577KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.00015 0.00056 0.00002DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.00104 0.00156 0.00000CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.07817 0.00005 0.15883NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
0.02197 0.00184 0.00019AMIT_EGF_RESPONSE_20_HELA
0.01515 0.01034 0.00024KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.00077 0.00000 0.01887BASSO_CD40_SIGNALING_UP
0.17512 0.00332 0.11195MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.07883 0.14706 0.14147BIOCARTA_NTHI_PATHWAY
0.04862 0.00004 0.01084MARZEC_IL2_SIGNALING_UP
0.00000 0.00000 0.00000NAGASHIMA_NRG1_SIGNALING_UP
0.00011 0.00027 0.02991SOUCEK_MYC_TARGETS
0.06561 0.18152 0.16237CORUM_IKBALPHA-RELA-CREL_COMPLEX
0.11657 0.04439 0.00050ENK_UV_RESPONSE_EPIDERMIS_DN
0.00543 0.01086 0.04093TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.00318 0.11589 0.00038ZERBINI_RESPONSE_TO_SULINDAC_UP
0.01698 0.17802 0.12713SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.19699 0.00628 0.06538FRIDMAN_SENESCENCE_UP
0.00624 0.00094 0.00343WU_HBX_TARGETS_2_DN
0.07884 0.07482 0.00037GENTILE_UV_LOW_DOSE_DN
0.01192 0.00122 0.14179NETPATH_B_CELL_RECEPTOR_PATHWAY_UP
0.00002 0.00001 0.05724MAHADEVAN_RESPONSE_TO_MP470_UP
0.00008 0.00156 0.00024FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.00029 0.00024 0.00000BILD_HRAS_ONCOGENIC_SIGNATURE
0.00031 0.00000 0.13850LIANG_SILENCED_BY_METHYLATION_2
0.00067 0.00307 0.00000DAUER_STAT3_TARGETS_UP
0.03326 0.00000 0.00810NETPATH_IL_3_PATHWAY_UP
0.04079 0.00619 0.01450ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.08290 0.02738 0.03617WANG_ESOPHAGUS_CANCER_PROGRESSION_UP
0.02309 0.11208 0.00585WU_HBX_TARGETS_1_UP
0.00015 0.03269 0.00000ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.00002 0.00102 0.00000AMIT_EGF_RESPONSE_60_HELA
0.08229 0.00358 0.00046BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.00289 0.14733 0.00146KANNAN_TP53_TARGETS_UP
0.09365 0.02275 0.00083AMUNDSON_DNA_DAMAGE_RESPONSE_TP53
0.00000 0.00291 0.00003CHEN_HOXA5_TARGETS_9HR_UP
0.00079 0.00111 0.00000DAZARD_UV_RESPONSE_CLUSTER_G2
0.00012 0.00163 0.11127NCI_CD40_PATHWAY
0.00874 0.00005 0.00000AMIT_SERUM_RESPONSE_40_MCF10A
0.00000 0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.05959 0.03402 0.00000NETPATH_EGFR1_PATHWAY_UP
0.00937 0.00003 0.00000GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00002 0.01806 0.00250CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.00000 0.00000 0.00001ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.03178 0.00001 0.14027PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.00014 0.06295 0.06732HELLER_SILENCED_BY_METHYLATION_DN
0.05612 0.01538 0.05987ENGELMANN_CANCER_PROGENITORS_UP
0.00586 0.02732 0.00416BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.00000 0.06472 0.00109BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
0.04863 0.00411 0.05157MARSON_FOXP3_TARGETS_DN
0.02541 0.01080 0.05989SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.01982 0.05272 0.00000WANG_METHYLATED_IN_BREAST_CANCER
0.04723 0.00223 0.05262XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.06289 0.15152 0.06477MATTIOLI_MGUS_VS_PCL
0.03557 0.00036 0.10479ONDER_CDH1_TARGETS_2_DN
0.04120 0.03717 0.08992SENESE_HDAC1_TARGETS_UP
0.00884 0.00557 0.13422MANALO_HYPOXIA_UP
0.12773 0.00111 0.00001INGA_TP53_TARGETS
0.00215 0.00004 0.00000HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.07116 0.00022 0.02726ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.00018 0.13254 0.00054UDAYAKUMAR_MED1_TARGETS_DN
0.00000 0.00017 0.00001KIM_WT1_TARGETS_UP
0.03411 0.02396 0.11682SENESE_HDAC3_TARGETS_UP
0.03876 0.13248 0.00114ONDER_CDH1_TARGETS_1_DN
0.00000 0.00336 0.00000UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.00018 0.00063 0.09671XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.00546 0.05653 0.04968BIOCARTA_KERATINOCYTE_PATHWAY
0.00067 0.05996 0.13073BIOCARTA_TNFR2_PATHWAY
0.04632 0.00000 0.00000HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.00023 0.00131 0.00000ELVIDGE_HYPOXIA_BY_DMOG_UP
0.07974 0.03956 0.00007DASU_IL6_SIGNALING_UP
0.02386 0.03134 0.00000AMIT_EGF_RESPONSE_120_MCF10A
0.00000 0.00009 0.00000GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.07010 0.06016 0.15861GOUYER_TATI_TARGETS_UP
0.05602 0.17224 0.00380MURAKAMI_UV_RESPONSE_6HR_DN
0.00010 0.00265 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.00723 0.00899 0.00000ZUCCHI_METASTASIS_DN
0.03851 0.12832 0.03483BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
0.14055 0.06878 0.00046BIOCARTA_ARENRF2_PATHWAY
0.00000 0.00099 0.00000PRAMOONJAGO_SOX4_TARGETS_UP
0.00306 0.07001 0.00887KIM_WT1_TARGETS_8HR_UP
0.17075 0.07788 0.05298CORUM_ETS2-FOS-JUN_COMPLEX
0.03302 0.01515 0.15598NCI_TCRJNKPATHWAY
0.00002 0.00107 0.00000PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.00221 0.04364 0.00069YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.04742 0.02625 0.03264ELVIDGE_HIF1A_TARGETS_DN